Investigating diagnostic, Prognostic, and therapeutic role of Long Non-Coding RNA MALAT1 in Breast Carcinoma: in silico study

Journal Title: DEVELOPMENTAL MEDICO-LIFE-SCIENCES - Year 2024, Vol 1, Issue 1

Abstract

Background: Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) is a nuclear-enriched long non-coding RNA, implicated in the tumorigenesis of various cancers, including breast carcinoma (BC). It is associated with cancer proliferation, invasion, migration, and metastasis, and plays a role in immune system modulation. Aims and Objectives: This in silico study investigates MALAT1's diagnostic, prognostic, and therapeutic potential in BC. It examines MALAT1's differential expression in Breast Cancer (BC) versus normal tissues, its impact on patient survival, and its interaction with miR-561 affecting TOP2A mRNA degradation. Methodology: Using publicly available datasets from GEO and TCGA, we conducted differential expression, survival, and prognostic analyses, along with network and pathway studies and drug repurposing analyzes and Tools like Graph Pad Prism and GEPIA data set was used for demographics. Results: Our analyzes indicate overexpression of MALAT1 in BC tissues, its correlation with poorer survival rates, and involvement in key oncogenic pathways. Additionally, drug repurposing analyzes have identified potential MALAT1-targeted therapeutic strategies. Conclusion: MALAT1 serves as a significant biomarker for BC diagnosis and prognosis and is identified as a potential therapeutic target. This study lays the groundwork for future research into MALAT1-targeted therapies in BC

Authors and Affiliations

ARSLAN SHUJA, MUHAMMAD NASIR SHAHBAZ , SUMAIRA SHARIF , AQSA IKRAM, MAMOONA SHUJA, NAVEED SHUJA

Keywords

Related Articles

Analysis of Patients Receiving Treatment for Inflammatory Breast Disease at Surgery Department of Tertiary Care Units

Background: In the Surgery Department of Tertiary Care Units, an analysis of patients receiving treatment for inflammatory breast disease presents a critical assessment of disease patterns and therapeutic outcomes. This...

Investigating diagnostic, Prognostic, and therapeutic role of Long Non-Coding RNA MALAT1 in Breast Carcinoma: in silico study

Background: Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) is a nuclear-enriched long non-coding RNA, implicated in the tumorigenesis of various cancers, including breast carcinoma (BC). It is associated...

Investigating the Link Between Left Ventricular Hypertrophy and Anemia in End-Stage Renal Disease

Background:ESRD significantly burdens healthcare systems worldwide. Its related complications, such as LVH and anemia, lead to increased morbidity and mortality. Left Ventricular Hypertrophy (LVH), which mirrors an incre...

Empathy Levels in Medical Students as they Advance through their Years of Education

Background: At Nishtar Medical University, medical students' empathy levels across different years of medical education were compared to identify and present any differences in empathy levels between the medical students...

ROLE OF NANO ENZYME IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF GASTROINTESTINAL TRACT (GIT) CANCER

Background:The most common life-threatening problem in population is gastrointestinal tract (GIT) cancer and its mortality rate is very high. Now a days Nanotechnology is a modern way of diagnosis and treatment. Nano-enz...

Download PDF file
  • EP ID EP735516
  • DOI -
  • Views 55
  • Downloads 0

How To Cite

ARSLAN SHUJA, MUHAMMAD NASIR SHAHBAZ, SUMAIRA SHARIF, AQSA IKRAM, MAMOONA SHUJA, NAVEED SHUJA (2024). Investigating diagnostic, Prognostic, and therapeutic role of Long Non-Coding RNA MALAT1 in Breast Carcinoma: in silico study. DEVELOPMENTAL MEDICO-LIFE-SCIENCES, 1(1), -. https://europub.co.uk./articles/-A-735516